Want to join the conversation?
Healthcare company $LLY said the US FDA has approved Taltz injection 80 mg/mL for treating moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Taltz will be available in the US beginning in second quarter of 2016.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.